All News #Library
Rare Diseases
SEED Therapeutics Doses 1st Patient in Phase 1 Trial of ST-01156
09 Jan 2026 //
GLOBENEWSWIRE
SEED Recieves Orphan Drug Designations For RBM39 Degrader
28 Jan 2025 //
GLOBENEWSWIRE

Market Place
Sourcing Support